mir-233 modulates the unfolded protein response in C. elegans during Pseudomonas aeruginosa infection.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Dai LL;Dai LL; Gao JX; Gao JX; Zou CG; Zou CG; Ma YC; Ma YC; Zhang KQ; Zhang KQ
  • Source:
    PLoS pathogens [PLoS Pathog] 2015 Jan 08; Vol. 11 (1), pp. e1004606. Date of Electronic Publication: 2015 Jan 08 (Print Publication: 2015).
  • Publication Type:
    Journal Article; Research Support, Non-U.S. Gov't
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE
    • Publication Information:
      Original Publication: San Francisco, CA : Public Library of Science, c2005-
    • Subject Terms:
    • Abstract:
      The unfolded protein response (UPR), which is activated by perturbations of the endoplasmic reticulum homeostasis, has been shown to play an important role in innate immunity and inflammation. However, little is known about the molecular mechanisms underlying activation of the UPR during immune responses. Using small RNA deep sequencing and reverse genetic analysis, we show that the microRNA mir-233 is required for activation of the UPR in Caenorhabditis elegans exposed to Pseudomonas aeruginosa PA14. P. aeruginosa infection up-regulates the expression of mir-233 in a p38 MAPK-dependent manner. Quantitative proteomic analysis identifies SCA-1, a C. elegans homologue of the sarco/endoplasmic reticulum Ca2+-ATPase, as a target of mir-233. During P. aeruginosa PA14 infection, mir-233 represses the protein levels of SCA-1, which in turn leads to activation of the UPR. Whereas mir-233 mutants are more sensitive to P. aeruginosa infection, knockdown of sca-1 leads to enhanced resistance to the killing by P. aeruginosa. Our study indicates that microRNA-dependent pathways may have an impact on innate immunity by activating the UPR.
    • References:
      Science. 2002 Jul 26;297(5581):623-6. (PMID: 12142542)
      Curr Opin Microbiol. 2002 Feb;5(1):97-101. (PMID: 11834377)
      Methods. 2003 Aug;30(4):313-21. (PMID: 12828945)
      Genetics. 1974 May;77(1):71-94. (PMID: 4366476)
      Cell. 1993 Dec 3;75(5):843-54. (PMID: 8252621)
      Methods Cell Biol. 1995;48:451-82. (PMID: 8531738)
      Nature. 1998 Oct 29;395(6705):854. (PMID: 9804418)
      Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14086-91. (PMID: 16968778)
      J Gen Physiol. 2006 Oct;128(4):443-59. (PMID: 16966474)
      PLoS Genet. 2006 Nov 10;2(11):e183. (PMID: 17096597)
      Nat Rev Mol Cell Biol. 2007 Jul;8(7):519-29. (PMID: 17565364)
      RNA. 2007 Sep;13(9):1492-504. (PMID: 17652138)
      Cell Metab. 2007 Oct;6(4):280-93. (PMID: 17908557)
      Am J Physiol Cell Physiol. 2008 Jan;294(1):C333-44. (PMID: 17942636)
      Nat Rev Mol Cell Biol. 2008 Mar;9(3):219-30. (PMID: 18270516)
      PLoS Genet. 2007 Dec;3(12):e215. (PMID: 18085825)
      PLoS Pathog. 2008 Oct;4(10):e1000176. (PMID: 18846208)
      Cell. 2009 Jan 23;136(2):215-33. (PMID: 19167326)
      Science. 2009 Jan 30;323(5914):630-3. (PMID: 19179530)
      Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2782-7. (PMID: 19196974)
      Nat Rev Immunol. 2010 Jan;10(1):47-58. (PMID: 20029447)
      Curr Biol. 2010 Feb 23;20(4):367-73. (PMID: 20096582)
      Nature. 2010 Feb 25;463(7284):1092-5. (PMID: 20182512)
      PLoS Genet. 2010 Apr;6(4):e1000892. (PMID: 20369020)
      Diabetes. 2010 Jun;59(6):1386-96. (PMID: 20299472)
      Mol Cell Biol. 2010 Nov;30(21):5033-42. (PMID: 20733002)
      Circ Res. 2011 Mar 4;108(5):629-42. (PMID: 21372294)
      Bioinformatics. 2011 May 1;27(9):1247-54. (PMID: 21422073)
      Pharmacol Rev. 2011 Sep;63(3):700-27. (PMID: 21737534)
      Proc Natl Acad Sci U S A. 2011 Nov 1;108(44):17997-8002. (PMID: 22011579)
      PLoS Genet. 2011 Nov;7(11):e1002391. (PMID: 22125500)
      Mol Cell. 2012 May 25;46(4):530-41. (PMID: 22503424)
      Mol Cell Proteomics. 2012 Jun;11(6):M111.014910. (PMID: 22240506)
      Diabetes. 2012 Oct;61(10):2609-20. (PMID: 22751695)
      Mol Cell Proteomics. 2013 Aug;12(8):2266-77. (PMID: 23665590)
      PLoS Pathog. 2013;9(8):e1003545. (PMID: 23990780)
      Infect Immun. 2013 Oct;81(10):3942-57. (PMID: 23918784)
      Nature. 2000 Feb 24;403(6772):901-6. (PMID: 10706289)
      Curr Biol. 2000 Nov 30;10(23):1539-42. (PMID: 11114525)
      Gene. 2000 Dec 31;261(2):211-9. (PMID: 11167007)
      J Biol Chem. 2001 Nov 23;276(47):43557-63. (PMID: 11559701)
      Nature. 2002 Jan 3;415(6867):92-6. (PMID: 11780124)
      J Cell Sci. 2003 May 15;116(Pt 10):1861-2. (PMID: 12692187)
    • Accession Number:
      0 (Antigens, Ly)
      0 (MIRN233 microRNA, C elegans)
      0 (MicroRNAs)
    • Publication Date:
      Date Created: 20150109 Date Completed: 20151005 Latest Revision: 20210109
    • Publication Date:
      20221213
    • Accession Number:
      PMC4287614
    • Accession Number:
      10.1371/journal.ppat.1004606
    • Accession Number:
      25569229